KH Neochem Co.,Ltd. (4189) AI Stock Analysis

• Market Cap: ¥102.58B
• Dividend Yield: 4.02%
• Average Volume (3M): 110.95K
• Price to Earnings (P/E): 11.3
• Beta (1Y): 0.63
• Revenue Growth: 2.61%
• EPS Growth: 30.29%
• Country: JP
• Employees: 829
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 48.18
• Shares Outstanding: 37,149,400
• 10 Day Avg. Volume: 104,350
• 30 Day Avg. Volume: 110,953
• PEG Ratio: 0.40
• Price to Book (P/B): 1.09
• Price to Sales (P/S): 0.63
• P/FCF Ratio: -52.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ¥2,707.00 ▲(11.72% Upside)

KH Neochem Co.,Ltd. has a robust financial foundation with strong valuation metrics. However, technical indicators suggest bearish momentum, which could pose short-term risks. The absence of earnings call data and corporate events limits further insights.

KH Neochem Co.,Ltd. Business Overview & Revenue Model

Company Description

KH Neochem Co., Ltd. (4189) is a leading chemical manufacturing company based in Japan, specializing in the production of fine chemicals and specialty materials. The company operates primarily in the chemical sector, focusing on the development and manufacturing of high-performance products such as amines, solvents, and other chemical intermediates. KH Neochem serves a diverse range of industries, including pharmaceuticals, agrochemicals, and electronics, leveraging its advanced technology and innovation to meet the specific needs of its clients.

How the Company Makes Money

KH Neochem generates revenue through the production and sale of its specialty chemical products. Its primary revenue streams include the sale of fine chemicals, which are utilized in various applications across multiple industries. The company maintains strong partnerships with key players in the pharmaceutical and electronics sectors, which contribute significantly to its earnings. Additionally, KH Neochem invests in research and development to innovate and expand its product offerings, thereby enhancing its market position and driving sales growth. The company's focus on high-quality products and customer service further solidifies its revenue generation capabilities.

KH Neochem Co.,Ltd. Financial Statement Overview

Summary

KH Neochem Co.,Ltd. demonstrates strong revenue growth and profitability with a solid balance sheet. However, declining margins and negative free cash flow in 2024 highlight potential financial challenges.

Income Statement

KH Neochem Co.,Ltd. demonstrated solid revenue growth with a 3.95% increase in 2024 over 2023. The company maintained a strong gross profit margin of 21.09% and a net profit margin of 6.98% in 2024, indicating consistent profitability. However, there is a slight decline in margins from previous years, pointing to potential cost pressures.

Balance Sheet

The company's debt-to-equity ratio is 0.28, reflecting a conservative leverage position. Return on Equity (ROE) stands at 12.10%, showcasing effective use of equity to generate profits. The equity ratio of 52.55% highlights a strong equity base, but the decreasing trend in equity ratio from previous years may signal increasing liabilities.

Cash Flow

Free cash flow turned negative in 2024, indicating cash flow challenges. The operating cash flow to net income ratio is 0.84, suggesting operational cash generation is trailing net income. The free cash flow to net income ratio is negative, which calls for attention to cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	122.59B	119.76B	115.22B	114.88B	117.11B	77.33B
Gross Profit	26.90B	25.25B	21.94B	24.45B	32.23B	16.14B
EBITDA	18.72B	17.00B	14.46B	16.01B	24.19B	9.48B
Net Income	8.99B	8.36B	6.83B	8.07B	13.69B	4.05B
Balance Sheet
Total Assets	125.88B	131.46B	124.50B	131.25B	122.07B	95.51B
Cash, Cash Equivalents and Short-Term Investments	5.40B	7.16B	9.68B	10.93B	16.93B	9.07B
Total Debt	20.63B	19.20B	16.39B	22.52B	20.16B	21.46B
Total Liabilities	55.23B	59.54B	58.01B	69.18B	64.57B	49.63B
Stockholders Equity	67.80B	69.09B	63.74B	59.35B	54.92B	43.38B
Cash Flow
Free Cash Flow	0.00	-1.45B	7.94B	-5.36B	13.00B	-4.20B
Operating Cash Flow	0.00	6.98B	13.20B	5.13B	17.40B	6.93B
Investing Cash Flow	0.00	-8.90B	-4.94B	-10.08B	-4.39B	-11.18B
Financing Cash Flow	0.00	-645.00M	-9.50B	-1.08B	-5.17B	-4.53B

KH Neochem Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2423.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4189, the sentiment is Negative. The current price of 2423 is below the 20-day moving average (MA) of 2687.25, below the 50-day MA of 2748.32, and below the 200-day MA of 2532.32, indicating a bearish trend. The MACD of -72.18 indicates Positive momentum. The RSI at 28.01 is Positive, neither overbought nor oversold. The STOCH value of 4.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4189.

KH Neochem Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4368	80 Outperform	¥199.83B	15.50	―	1.48%	8.80%	33.39%
4220	77 Outperform	¥66.74B	8.29	―	3.36%	2.02%	30.10%
4041	74 Outperform	¥190.69B	13.54	―	4.27%	3.26%	-13.75%
4097	74 Outperform	¥57.08B	12.47	―	2.87%	5.20%	-1.83%
5013	74 Outperform	¥29.08B	5.85	―	4.52%	3.47%	33.32%
4189	64 Neutral	¥102.58B	11.31	―	4.02%	2.61%	30.29%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

KH Neochem Co.,Ltd. Corporate Events

KH Neochem Reports Strong Earnings Growth Despite Slight Sales Decline

KH Neochem Co., Ltd. reported its consolidated financial results for the nine months ending September 30, 2025, showing a slight decrease in net sales by 0.2% compared to the previous year. However, the company experienced significant growth in operating income, ordinary income, and net income attributable to owners of the parent, with increases of 16.2%, 15.0%, and 14.3% respectively. The company’s comprehensive income also rose by 17.2%. These results indicate a strong operational performance despite a slight dip in sales, suggesting an effective cost management strategy and operational efficiency.

The most recent analyst rating on (JP:4189) stock is a Buy with a Yen3031.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.

KH Neochem Completes Share Buyback

KH Neochem Co., Ltd. has completed the acquisition of its own shares, purchasing 127,800 common shares for 360,579,900 yen through market purchases on the Tokyo Stock Exchange. This acquisition is part of a broader resolution by the Board of Directors to buy back up to 2,500,000 shares, with a total cost not exceeding 5 billion yen, which is aimed at enhancing shareholder value and optimizing capital structure.

The most recent analyst rating on (JP:4189) stock is a Buy with a Yen3266.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.